These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10336506)

  • 21. Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels.
    Elefante A; Muindi J; West K; Dunford L; Abel S; Paplham P; Brown K; Hahn T; Padmanabhan S; Battiwalla M; McCarthy PL
    Bone Marrow Transplant; 2006 Apr; 37(8):781-4. PubMed ID: 16518428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of enrofloxacin and a low dose of amikacin administered via regional intravenous limb perfusion in standing horses.
    Parra-Sanchez A; Lugo J; Boothe DM; Gaughan EM; Hanson RR; Duran S; Belknap JK
    Am J Vet Res; 2006 Oct; 67(10):1687-95. PubMed ID: 17014317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher intracerebral concentration of tacrolimus after intermittent than continuous administration to rats.
    Sakamoto Y; Makuuchi M; Harihara Y; Imamura H; Sato H
    Liver Transpl; 2001 Dec; 7(12):1071-6. PubMed ID: 11753909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administration of tacrolimus in 50 liver transplantation patients.
    Ye QF; Ruzig MA; Gong NQ
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):492-4. PubMed ID: 14607673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High trough levels of oral FK506 induced by loss of small intestine.
    Sano N; Nio M; Shimaoka S; Ishii T; Amae S; Wada M; Ohi R
    Pediatr Transplant; 2001 Dec; 5(6):434-8. PubMed ID: 11737769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors].
    Hamazaki T; Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Sasabe M; Kishimoto T; Inoue A; Kawa K
    Rinsho Ketsueki; 2000 May; 41(5):430-6. PubMed ID: 10879106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
    Neuwelt EA; Pagel MA; Hasler BP; Deloughery TG; Muldoon LL
    Cancer Res; 2001 Nov; 61(21):7868-74. PubMed ID: 11691805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrolimus clearance is age-dependent within the pediatric population.
    Przepiorka D; Blamble D; Hilsenbeck S; Danielson M; Krance R; Chan KW
    Bone Marrow Transplant; 2000 Sep; 26(6):601-5. PubMed ID: 11041564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles.
    Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
    J Control Release; 2005 May; 104(2):337-46. PubMed ID: 15907584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hypomagnesaemic action of FK506: urinary excretion of magnesium and calcium and the role of parathyroid hormone.
    Lote CJ; Thewles A; Wood JA; Zafar T
    Clin Sci (Lond); 2000 Oct; 99(4):285-92. PubMed ID: 10995593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion.
    Woolley SM; Farivar AS; Naidu BV; Rosengart M; Thomas R; Fraga C; Mulligan MS
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):376-84. PubMed ID: 14762344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
    Chen YH; Liang YX; Chen LQ; Liang JJ; Zhang J; Qiu J; Li WL; Hu JB; Xie KJ; Zhong WD; Chen LZ; Zheng KL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2235-7. PubMed ID: 18001539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB.
    Lan CC; Yu HS; Wu CS; Kuo HY; Chai CY; Chen GS
    Br J Dermatol; 2005 Oct; 153(4):725-32. PubMed ID: 16181452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
    Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice.
    Lopes CT; Gallo AP; Palma PV; Cury PM; Bueno V
    Transplant Proc; 2008 Apr; 40(3):856-60. PubMed ID: 18455036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
    Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The consequences of tacrolimus blood concentrations during the four weeks following marrow transplantation from an unrelated donor: a single-center experience.
    Muta T; Kato K; Gondo H; Oku S; Okeda A; Kamo M; Nawata R; Takase K; Arima F; Shibuya T; Eto T
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):99-104. PubMed ID: 18195535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.